Zoe Billinghurst/ LinkedIn
Jun 14, 2026, 15:51
Zoe Billinghurst: Strengthening the Global Rare Blood Disorders Community at EHA 2026
Zoe Billinghurst, Senior Global Brand Director of Rare Blood and Renal Disorders at Novo Nordisk, shared post on LinkedIn:
“Building insights about Rare Blood Disorders – global unmet needs, clinical practice, research advances – steps forward since EHA 2025.
Building on established collaborations and instigating new ones. Amazing and intense week in Stockholm at EHA 2026 with amazing colleagues from Novo Nordisk Rare Disease team.”
Stay updated with Hemostasis Today.
-
Jun 14, 2026, 15:39Yaser Jenab: Proud to Contribute to the RIETE Registry
-
Jun 14, 2026, 15:34Anna A. Avagyan: Young Voices and Shared Purpose at EHA 2026
-
Jun 14, 2026, 14:05Tim Brümmendorf: Building a Successful Scientific Career in Hematology and Beyond at EHA 2026
-
Jun 14, 2026, 13:56Ruxandra Irimia: Honored to Be Elected Chair of YoungEHA
-
Jun 14, 2026, 12:25Izatul Natasha: Proud to Win the Best Overall Presentation on World Hemophilia Day
-
Jun 14, 2026, 12:20Sudhir Kumar: Homocysteine as An Overlooked Blood Test That May Reveal Important Health Risks
-
Jun 14, 2026, 12:03Grigoris Gerotziafas: Proud Moment for Team CaVITE at EHA 2026
-
Jun 14, 2026, 11:55VAYHIT3: Durable 12-Month Responses with Ianalumab in Primary ITP
-
Jun 14, 2026, 11:47Michael Makris: Proud to Present New Insights into Predicting Stroke Severity and Recovery at EHA 2026